REACTOGENITY AND SAFETY OF ADSORBED VACCINES AGAINST DIPHTERIA, TETANUS AND PERTUSSIS (DTAP): OBSERVATIONAL MULTICENTRAL TRIAL

REACTOGENITY AND SAFETY OF ADSORBED VACCINES AGAINST DIPHTERIA, TETANUS AND PERTUSSIS (DTAP): OBSERVATIONAL MULTICENTRAL TRIAL

Show other versions (1)

The purpose of this prospective multicenter surveillance study is evaluation of safety and reactogenicity of DTP vaccines, registered in Russia. 1424 children aged 12–20 weeks were enrolled in this study, 822 infants were vaccinated by AKDS, 411 — infanrix, 191 — tetracoc. The frequency and severity...

Full description

Bibliographic Details
Main Authors:	V.K. Tatochenko, L.S. Namazova, S.M. Kharit, O.A. Alikova, S.V. Bogidaev
Format:	Article
Language:	English
Published:	"Paediatrician" Publishers LLC 2006-07-01
Series:	Вопросы современной педиатрии
Subjects:	vaccines reactogenicity adverse events surveillance study
Online Access:	https://vsp.spr-journal.ru/jour/article/view/753

Similar Items

REACTOGENITY AND SAFETY OF ADSORBED VACCINES AGAINST DIPHTERIA, TETANUS AND PERTUSSIS (DTAP): OBSERVATIONAL MULTICENTRAL TRIAL
by: V.K. Tatochenko, et al.
Published: (2006-01-01)

Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy Russian participants: a phase III, open-label study
by: Asmik Asatryan, et al.
Published: (2021-03-01)

Safety and Immunogenicity of Fully Liquid Hexavalent DTaP-IPV-HepB-Hib Vaccine in Healthy Infants in Russian Federation
by: L. S. Namazova-Baranova, et al.
Published: (2019-06-01)

COMPARISON OF REACTOGENICITY AND IMMUNOGENICITY OF LIVE VACCINES AGAINST INFECTIOUS LARYNGOTRACHEITIS
by: S. A. Pokhvalny, et al.
Published: (2018-05-01)

The Relationship between Immunogenicity and Reactogenicity of Seasonal Influenza Vaccine Using Different Delivery Methods
by: Daniel J. Gromer, et al.
Published: (2024-07-01)

REACTOGENITY OF TICK-BORNE ENCEPHALITIS VACCINE ENCEPUR ADULT AND IMMUNE RESPONSE
by: G. N. Leonova, et al.
Published: (2014-07-01)

COMBINED VACCINES IN PEDIATRIC PRACTICE: WHEN THE PERTUSSIS VACCINE IS FUN!
by: V. K. Tatochenko
Published: (2012-08-01)

THE EVALUATION OF REACTOGENICITY, SAFETY AND IMMUNOGENICITY OF THE POLYSACCHARIDE PNEUMOCOCCAL VACCINE DURING THE IMMUNIZATION OF HEALTH CARE WORKERS
by: I. V. Feldblum, et al.
Published: (2014-06-01)

Immunogenicity and Reactogenicity in Q Fever Vaccine Development
by: Alycia P. Fratzke, et al.
Published: (2022-05-01)

RESULTS OF A MULTICENTER CLINICAL STUDY OF A NEW COMBINATION VACCINE DTaP-HepB+Hib PRODUCTION OF THE CPA «MICROGEN» FOR IMMUNIZATION OF CHILDREN 6 MONTHS
by: I. V. Feldblyum, et al.
Published: (2018-04-01)

Editorial: Non-reactogenic vaccines against Q-fever
by: Anthony E. Gregory, et al.
Published: (2023-05-01)

Reactogenicity of various COVID-19 vaccination regimens
by: O. M. Drapkina, et al.
Published: (2023-01-01)

Methods for predicting vaccine immunogenicity and reactogenicity
by: Patrícia Gonzalez-Dias, et al.
Published: (2020-02-01)

A randomized Phase I/II study to evaluate safety and reactogenicity of a heat-stable rotavirus vaccine in healthy adults followed by evaluation of the safety, reactogenicity, and immunogenicity in infants
by: Vibhu Kanchan, et al.
Published: (2020-03-01)

Association of Reactogenicity with Immunogenicity of the ChAdOx1 nCoV-19 Vaccine in Patients Undergoing Hemodialysis
by: Ting-Yun Lin, et al.
Published: (2022-08-01)

From Bench to Bedside: Implications of Lipid Nanoparticle Carrier Reactogenicity for Advancing Nucleic Acid Therapeutics
by: Tetiana Korzun, et al.
Published: (2023-07-01)

Understanding immunity differences induced by whole cell and acellular pertussis vaccines in a paediatric population
by: Martins Valente Pinto, AM
Published: (2021)

A Case of Immune Thrombocytopenia After Diphteria-Tetanus Vaccine
by: Tuba Kasap, et al.
Published: (2019-03-01)

Reactogenicity and Immunogenicity Against MPXV of the Intradermal Administration of Modified Vaccinia Ankara Compared to the Standard Subcutaneous Route
by: Valentina Mazzotta, et al.
Published: (2024-12-01)

Reactogenicity, safety and immunological efficacy of the live, pentavalent rotavirus vaccine in childhood immunization (results of the multicenter clinical trial)
by: Irina V. Feldblium, et al.
Published: (2020-09-01)

Real-World Immunogenicity and Reactogenicity of Two Doses of Pfizer-BioNTech COVID-19 Vaccination in Children Aged 5–11 Years
by: Gili Joseph, et al.
Published: (2022-11-01)

Association between Reactogenicity and Immunogenicity after Vaccination with BNT162b2
by: Stilla Bauernfeind, et al.
Published: (2021-09-01)

Evaluating the reactogenicity of COVID-19 vaccines from network-meta analyses
by: Giorgia Tiozzo, et al.
Published: (2023-12-01)

Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) in Children 9–23 Months of Age in Russian Federation: Results of Russian Part of International Study in Russia and India
by: O. A. Perminova, et al.
Published: (2020-05-01)

Influence of the reactogenity of the tick-borne encephalitis vaccines on the immune response in vaccinated people
by: G. N. Leonova, et al.
Published: (2006-12-01)

Immunogenicity and reactogenicity following MMR vaccination in 5–7-month-old infants: a double-blind placebo-controlled randomized clinical trial in 6540 Danish infantsResearch in context
by: Dorthe Maria Vittrup, et al.
Published: (2024-02-01)

Comparing reactogenicity of COVID-19 vaccine boosters: a systematic review and meta-analysis
by: Alberto San Francisco Ramos, et al.
Published: (2024-12-01)

Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine in children and adolescents 6 months through 17 years of age in India
by: Nijalingappa K. Kalappanavar, et al.
Published: (2022-11-01)

Reactogenicity of Cervarix and Gardasil human papillomavirus (HPV) vaccines in a randomized single blind trial in healthy UK adolescent females
by: Tao Haskins-Coulter, et al.
Published: (2017-06-01)

Adherence and Reactogenicity to Vaccines against SARS-COV-2 in 285 Patients with Neuropathy: A Multicentric Study
by: Salvatore Iacono, et al.
Published: (2022-10-01)

REACTOGENICITY OF ACELLULAR PERTUSSIS VACCINE AND THE POSSIBILITY OF ITS USE IN ELDER CHILDREN
by: M.G. Galitskaya, et al.
Published: (2008-01-01)

REACTOGENICITY OF ACELLULAR PERTUSSIS VACCINE AND THE POSSIBILITY OF ITS USE IN ELDER CHILDREN
by: M.G. Galitskaya, et al.
Published: (2008-01-01)

Self-Reported Real-World Safety and Reactogenicity of COVID-19 Vaccines: A Vaccine Recipient Survey
by: Alexander G. Mathioudakis, et al.
Published: (2021-03-01)

Predictive Value of Reactogenicity for Anti-SARS-CoV-2 Antibody Response in mRNA-1273 Recipients: A Multicenter Prospective Cohort Study
by: Min Joo Choi, et al.
Published: (2023-01-01)

Reactogenicity within the first week after Sinopharm, Sputnik V, AZD1222, and COVIran Barekat vaccines: findings from the Iranian active vaccine surveillance system
by: Mostafa Enayatrad, et al.
Published: (2023-03-01)

VACCINATION OF PREMATURE/LOW-BIRTH-WEIGHT CHILDREN
by: V. K. Tatochenko
Published: (2013-07-01)

Effect of gender, age and vaccine on reactogenicity and incapacity to work after COVID-19 vaccination: a survey among health care workers
by: Irit Nachtigall, et al.
Published: (2022-03-01)

Burden and Impact of Reactogenicity among Adults Receiving COVID-19 Vaccines in the United States and Canada: Results from a Prospective Observational Study
by: Matthew D. Rousculp, et al.
Published: (2024-01-01)

Post hoc analysis of reactogenicity trends between dose 1 and dose 2 of the adjuvanted recombinant zoster vaccine in two parallel randomized trials
by: Romulo Colindres, et al.
Published: (2020-11-01)

Efficacy, reactogenicity, and safety of the adjuvanted recombinant zoster vaccine for the prevention of herpes zoster in Chinese adults ≥ 50 years: A randomized, placebo-controlled trial
by: Diana Alexandra Echeverria Proano, et al.
Published: (2024-12-01)